| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Ehrlich Christopher B | Chairman and CEO, Director | CERO THERAPEUTICS HOLDINGS, INC., 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO | /s/ Andrew Kucharchuk, Attorney-in-Fact | 09 Jan 2026 | 0001293973 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CERO | Stock Option (Right to Buy) | Award | $0 | +4,530,997 | $0.000000 | 4,530,997 | 07 Jan 2026 | Common Stock | 4,530,997 | $0.0550 | Direct |